Aurora A and AKT Kinase Signaling Associated with Primary Cilia

Yuhei Nishimura1,2, Daishi Yamakawa3, Takashi Shiromizu1

  • 1Department of Integrative Pharmacology, Graduate School of Medicine, Mie University, Tsu 514-8507, Japan.

Cells
|December 24, 2021
PubMed

Insights

Kinase signaling dysregulation, particularly involving aurora A and AKT kinases, contributes to diseases like cancer and obesity. Targeting these kinases within primary cilia offers a context-specific therapeutic approach.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Kinase signaling pathways are crucial for cellular processes but their dysregulation is linked to diseases like cancer, inflammation, and autoimmunity.
  • Context-specific targeting of kinases is essential for therapeutic efficacy and reducing adverse effects.
  • Primary cilia are cellular antennae involved in sensing extracellular cues and signal transduction, with their dysregulation implicated in various diseases.

Purpose of the Study:

  • To review the role of primary cilia-associated signaling pathways involving aurora A and AKT kinases.
  • To explore the connection between these kinase pathways and diseases such as cancer, obesity, and ciliopathies.

Main Methods:

  • Literature review of scientific articles focusing on kinase signaling, primary cilia, cancer, obesity, and ciliopathies.
  • Analysis of the context-dependent mechanisms of cilia formation and signaling.
  • Examination of the involvement of aurora A and AKT kinases in primary cilia-associated diseases.

Main Results:

  • Dysregulation of aurora A and AKT kinase signaling within primary cilia is associated with pathological conditions.
  • Context-dependent mechanisms of primary cilia regulate kinase signaling, influencing disease development.
  • Targeting these specific kinase pathways in primary cilia may offer novel therapeutic strategies.

Conclusions:

  • Primary cilia play a critical role in cellular signaling, and their dysfunction contributes to disease.
  • Aurora A and AKT kinases are key players in primary cilia-associated signaling pathways relevant to cancer and obesity.
  • Context-selective targeting of these kinases offers a promising avenue for developing more specific and effective therapies.

Related Concept Videos

Microtubules in Signaling01:22

Microtubules in Signaling

The primary cilium, made up of microtubules, acts as antennae on the cell surfaces for relaying external stimuli into the cells. These fine hair-like structures are present, generally one per cell. These are non-motile cilia in a 9+0 microtubules arrangement, where the central pair of microtubules are absent. The primary cilia arise from the basal body embedded in the cell membrane. Intraflagellar transport (IFT) carries requisite proteins from the cytoplasm to the cilium because the primary...
1.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.4K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
12.9K